Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-01 Sale | 2021-03-02 4:07 pm | VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer | 2,782 | $211.45 | $588,255 | 10,053 (Indirect Direct) | View |
| 2021-02-25 Sale | 2021-02-26 4:23 pm | VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer | 1,080 | $213.47 | $230,552 | 15,053 (Indirect Direct) | View |
| 2021-02-18 Sale | 2021-02-19 4:21 pm | VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer | 4,295 | $211.83 | $909,828 | 16,997 (Indirect Direct) | View |
| 2021-02-11 Sale | 2021-02-16 4:24 pm | VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer | 1,498 | $210.57 | $315,437 | 24,032 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-17 Option Award | 2025-06-18 4:15 pm | N/A 2035-06-17 | Rapport Therapeutics Inc. | RAPP | Silva Paul M Director | 10,925 | $0 | 10,925 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:33 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Silva Paul M Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-11-07 Option Award | 2024-11-07 6:59 pm | N/A 2034-11-07 | Rapport Therapeutics Inc. | RAPP | Silva Paul M Director | 29,756 | $0 | 29,756 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-20 7:26 pm | N/A 2034-05-19 | Nurix Therapeutics Inc. | NRIX | Silva Paul M Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-04 8:00 pm | N/A 2033-05-03 | Nurix Therapeutics Inc. | NRIX | Silva Paul M Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-06 5:44 pm | N/A 2032-05-04 | Nurix Therapeutics Inc. | NRIX | Silva Paul M Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2021-10-01 Option Award | 2021-10-04 5:15 pm | N/A 2031-09-30 | Nurix Therapeutics Inc. | NRIX | Silva Paul M Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2021-02-26 Tax Withholding | 2021-03-02 4:07 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer | 2,218 | $212.42 | 10,053 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-26 4:23 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer | 864 | $217.57 | 15,053 (Direct) | View |
| 2021-02-17 Tax Withholding | 2021-02-19 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer | 2,740 | $211.75 | 16,997 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-12 4:16 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer | 651 | $214.16 | 25,530 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 4:57 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer | 11,080 | $0 | 26,181 (Direct) | View |